← All trials
NCT04797936
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2020
- Primary completion
- Dec 19, 2020
- Completion date
- Jan 8, 2021
- First posted
- Mar 15, 2021
- Last posted
- Mar 15, 2021
- Enrollment
- 133
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Ivano-Frankivsk National Medical UniversityLead sponsor
- Ivano-Frankivsk National Medical UniversityReponsible party - principal investigator
- Ivano-Frankivsk National Medical UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.